GlassScriptPhysician profile
Karen Young
NPI 1457362501
$4,026.67
in general payments reported to CMS, 2019-2025
17 companies · $1,302 in 2025
The $1,302 reported for 2025 was more than what 83% of Ophthalmology providers received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $422 · 2020: $380 · 2021: $188 · 2022: $187 · 2023: $123 · 2024: $1,425 · 2025: $1,302.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,832 · Education: $17.84.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,831.78 |
| Education | $17.84 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lumenis Be INC | $2,186.77 | 2024-2025 | Optilight, M22 |
| Abbvie INC. | $316.68 | 2022-2025 | Ozurdex |
| Allergan, INC. | $291.19 | 2019-2022 | |
| Kala Pharmaceuticals, INC. | $274.80 | 2019-2020 | |
| Sun Pharmaceutical Industries INC. | $244.94 | 2020-2025 | Cequa |
| Aerie Pharmaceuticals, INC. | $157.82 | 2020-2021 | |
| Bausch & Lomb Americas INC. | $128.34 | 2022-2025 | Xiidra, Vyzulta, Miebo |
| Novartis Pharmaceuticals Corporation | $105.85 | 2019-2020 | |
| Regeneron Healthcare Solutions, INC. | $63.38 | 2025 | Eylea Hd |
| New World Medical,INC. | $60.61 | 2019 | |
| Harrow Eye, LLC | $46.49 | 2024-2025 | Iheezo, Vevye |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $37.50 | 2019-2021 | |
| Alcon Vision LLC | $33.42 | 2022-2024 | Hydrus Microstent |
| Horizon Therapeutics Plc | $24.26 | 2021 | |
| Genentech USA, INC. | $19.67 | 2022 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Carl Zeiss Meditec Ag | $19.40 | 2020 | |
| Apellis Pharmaceuticals, INC. | $15.55 | 2023 | Syfovre |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Karen Young listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.